SCHEMBL9909804

SCHEMBL9909804

CCCCCCCCCCCCOc1cc(/C=C/c2ccc(N(CC)CC)cc2)c(OC)cc1/C=C/c1ccc(N(CC)CC)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
ALDH1A1 P00352 1/20 0.45
FGFR1 P11362 1/20 0.45
CYP1A1 P04798 2/20 0.43
CYP1B1 Q16678 2/20 0.43
CYP1A2 P05177 1/20 0.42
AHR P35869 1/20 0.42
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
INSR P06213 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.41
GFER P55789 1/20 0.41
PTGS2 P35354 1/20 0.40
TUBB4A P04350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3795581 0.91 L3MBTL1 (0.43) L3MBTL1ALDH1A1FGFR1CYP1A1CYP1B1
SCHEMBL3795577 0.91 L3MBTL1 (0.43) L3MBTL1ALDH1A1FGFR1CYP1A1CYP1B1
SCHEMBL13778821 0.87 ALDH1A1 (0.56) L3MBTL1ALDH1A1FGFR1CYP1A1CYP1B1
SCHEMBL19583345 0.87 ALDH1A1 (0.56) L3MBTL1ALDH1A1FGFR1CYP1A1CYP1B1
SCHEMBL18159325 0.84 SLC16A3 (0.38) ALDH1A1CYP1A1CYP1B1CYP1A2AHR
SCHEMBL9909806 0.83 AHR (0.49) L3MBTL1ALDH1A1CYP1A1CYP1B1CYP1A2
SCHEMBL12780790 0.83 ALDH1A1 (0.40) L3MBTL1ALDH1A1CYP1A1CYP1B1CYP1A2
SCHEMBL3029731 0.82 TUBB1 (0.46) FGFR1CYP1A1CYP1B1CYP1A2AHR
SCHEMBL3029733 0.82 TUBB1 (0.46) FGFR1CYP1A1CYP1B1CYP1A2AHR
SCHEMBL13230035 0.82 CYP1A1 (0.38) ALDH1A1CYP1A1CYP1B1CYP1A2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8192917-B2 Material for multiphoton fluorescence microscope and multiphoton fluorescence microscope RICOH COMPANY, LTD. (JP) 2012-06-05 US disclosed
US-20090323508-A1 PHOTOSENSITIZED COMPOSITE MATERIAL, THREE-DIMENSIONAL MEMORY MATERIAL AND RECORDING MEDIUM, OPTICAL POWER LIMITING MATERIAL AND ELEMENT, AND PHOTOCURING MATERIAL AND STEREOLITHOGRAPHY SYSTEM, AND FLUORESCENT MATERIAL FOR MULTIPHOTON FLUORESCENCE MICROSCOPE AND MULTIPHOTON FLUORESCENCE MICROSCOPE RICOH COMPANY, LTD. (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090323508-A1 PHOTOSENSITIZED COMPOSITE MATERIAL, THREE-DIMENSIONAL MEMORY MATERIAL AND RECORDING MEDIUM, OPTICAL POWER LIMITING MATERIAL AND ELEMENT, AND PHOTOCURING MATERIAL AND STEREOLITHOGRAPHY SYSTEM, AND FLUORESCENT MATERIAL FOR MULTIPHOTON FLUORESCENCE MICROSCOPE AND MULTIPHOTON FLUORESCENCE MICROSCOPE HTR3D, ORAI3, GRIN3A L3MBTL1 2400/4885ALDH1A1 1777/4885FGFR1 4117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.